StocktoriaShuttle Pharmaceuticals Holdings, Inc. SHPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
-26.44
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$11.9M | -$7.7M | -$5.9M | -$2.6M | -$1.7M |
| Net income | -$11.7M | -$9.1M | -$6.6M | -$3.0M | -$1.2M |
| Operating cash flow | -$9.5M | -$7.3M | -$5.6M | -$2.7M | -$300,336 |
| Free cash flow | — | — | -$5.6M | — | — |
| Total assets | $10.5M | $2.5M | $6.0M | $8.7M | $651,641 |
| Total liabilities | $8.2M | $1.8M | $1.9M | $975,676 | $2.3M |
| Shareholders' equity | $2.3M | $709,152 | $4.1M | $7.7M | -$1.6M |
| Ratios | |||||
| Return on assets | -111.9% | -364.9% | -110.8% | -35.0% | -176.8% |
| Return on equity | -519.9% | -1289.5% | -162.6% | -39.4% | 70.8% |
| Debt / equity | — | — | — | — | -0.06× |
| Current ratio | 0.06 | 1.44 | 5.37 | 8.79 | 0.23 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -26.44 (distress)
- Working capital / assets -0.712
- Retained earnings / assets -4.42
- EBIT / assets -1.138
- Equity / liabilities 0.274
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001757499 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.